DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $322,000 | -10.8% | 1,098 | 0.0% | 0.02% | -8.0% |
| Q4 2021 | $361,000 | +8.1% | 1,098 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $334,000 | +15.2% | 1,098 | +1.8% | 0.02% | +13.6% |
| Q2 2021 | $290,000 | +19.3% | 1,079 | 0.0% | 0.02% | +10.0% |
| Q1 2021 | $243,000 | +1.2% | 1,079 | 0.0% | 0.02% | -4.8% |
| Q4 2020 | $240,000 | +3.4% | 1,079 | 0.0% | 0.02% | -8.7% |
| Q3 2020 | $232,000 | +4.5% | 1,079 | -30.6% | 0.02% | -4.2% |
| Q2 2019 | $222,000 | +8.3% | 1,555 | 0.0% | 0.02% | +9.1% |
| Q1 2019 | $205,000 | -38.6% | 1,555 | -54.4% | 0.02% | -35.3% |
| Q1 2018 | $334,000 | +2.1% | 3,409 | -3.2% | 0.03% | +3.0% |
| Q4 2017 | $327,000 | +8.3% | 3,523 | 0.0% | 0.03% | +3.1% |
| Q3 2017 | $302,000 | +24.3% | 3,523 | +22.3% | 0.03% | +18.5% |
| Q2 2017 | $243,000 | -1.2% | 2,880 | 0.0% | 0.03% | -3.6% |
| Q1 2017 | $246,000 | +9.8% | 2,880 | 0.0% | 0.03% | 0.0% |
| Q4 2016 | $224,000 | -0.9% | 2,880 | 0.0% | 0.03% | -3.4% |
| Q3 2016 | $226,000 | -20.1% | 2,880 | +2.9% | 0.03% | -25.6% |
| Q2 2016 | $283,000 | +6.4% | 2,800 | 0.0% | 0.04% | +2.6% |
| Q1 2016 | $266,000 | +2.3% | 2,800 | 0.0% | 0.04% | +5.6% |
| Q4 2015 | $260,000 | +2.8% | 2,800 | -5.7% | 0.04% | -7.7% |
| Q3 2015 | $253,000 | -0.4% | 2,969 | 0.0% | 0.04% | +5.4% |
| Q2 2015 | $254,000 | +0.8% | 2,969 | 0.0% | 0.04% | +2.8% |
| Q1 2015 | $252,000 | +5.0% | 2,969 | +6.0% | 0.04% | 0.0% |
| Q4 2014 | $240,000 | +12.7% | 2,800 | 0.0% | 0.04% | +5.9% |
| Q3 2014 | $213,000 | -3.2% | 2,800 | 0.0% | 0.03% | -5.6% |
| Q2 2014 | $220,000 | -31.9% | 2,800 | -35.0% | 0.04% | -18.2% |
| Q1 2014 | $323,000 | +1.3% | 4,306 | +4.2% | 0.04% | 0.0% |
| Q4 2013 | $319,000 | – | 4,131 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |